DeepMed Research

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Cognitive Speed as an Objective Measure of Tinnitus

Completed

Conditions: Tinnitus

First Posted Date: 2011-07-15

Last Posted Date: 2012-08-23

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 108

Registration Number: NCT01395368

Locations: 🇺🇸
Washington University, St. Louis, Missouri, United States

Azacitidine After Chemotherapy and Donor Lymphocyte Infusion in Patients With Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome Previously Treated With Donor Stem Cell Transplant

Phase 1

Completed

Conditions: Myelodysplastic Syndromes
Leukemia, Myeloid, Acute

Interventions: Drug: Pre-DLI Salvage Chemotherapy
Drug: Azacitidine
Biological: Donor Leukocyte Infusion (DLI)

First Posted Date: 2011-07-11

Last Posted Date: 2015-04-27

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 14

Registration Number: NCT01390311

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

PD4PD:Partnered Dance for Parkinson Disease

Phase 2

Completed

Conditions: Parkinson Disease

Interventions: Behavioral: Tango dancing

First Posted Date: 2011-07-06

Last Posted Date: 2015-12-09

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 62

Registration Number: NCT01388556

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Exploration of Cortical Neural Network in Patients With Bothersome Tinnitus

Terminated

Conditions: Tinnitus

Interventions: Behavioral: Task-Based Functional Magnetic Resonance Imaging (fMRI)

First Posted Date: 2011-06-30

Last Posted Date: 2012-03-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 7

Registration Number: NCT01385540

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency

Phase 2

Terminated

Conditions: Alpha-1-antitrypsin Deficiency
Liver Cirrhosis

Interventions: Drug: Drug-Carbamazepine (Tegretol XR)
Drug: Carbamazepine (Tegretol XR) Placebo

First Posted Date: 2011-06-23

Last Posted Date: 2021-10-12

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 20

Registration Number: NCT01379469

Locations: 🇺🇸
Washington University in St. Louis School of Medicine, Saint Louis, Missouri, United States
🇺🇸
Children's Hospital of Pittsburgh, UPMC, Pittsburgh, Pennsylvania, United States
🇺🇸
University of Pittsburgh Medical Center, Presbyterian Hospital, Pittsburgh, Pennsylvania, United States

Role of Dopamine Receptors in Primary Focal Dystonias

Completed

Conditions: Focal Dystonias
Healthy

First Posted Date: 2011-06-15

Last Posted Date: 2018-05-15

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 40

Registration Number: NCT01373840

Locations: 🇺🇸
Washington University, Saint Louis, Missouri, United States

Nutritional Therapy for Diabetic Cardiomyopathy

Completed

Conditions: T2DM (Type 2 Diabetes Mellitus)

First Posted Date: 2011-06-15

Last Posted Date: 2024-01-11

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 22

Registration Number: NCT01373814

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Reversal of Obesity Cardiomyopathy

Completed

Conditions: Cardiomyopathy

First Posted Date: 2011-06-13

Last Posted Date: 2024-02-14

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 27

Registration Number: NCT01372397

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer

Phase 2

Terminated

Conditions: Estrogen Receptor-positive Breast Cancer
Stage II Breast Cancer
Stage IIIC Breast Cancer
Stage IIIB Breast Cancer
HER2-negative Breast Cancer
Stage IIIA Breast Cancer

Interventions: Drug: goserelin acetate
Drug: letrozole
Drug: anastrozole
Procedure: Surgery
Drug: chemotherapy

First Posted Date: 2011-06-07

Last Posted Date: 2015-04-03

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 8

Registration Number: NCT01368263

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Comparative Urine Proteomic Studies of Overactive Bladder in Humans

Not Applicable

Completed

Conditions: Overactive Bladder

Interventions: Drug: fesoterodine

First Posted Date: 2011-06-07

Last Posted Date: 2015-02-27

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 21

Registration Number: NCT01367886

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy